Mallinckrodt’s Terlipressin Narrowly Clears US FDA Panel As Need For Liver Treatment Outweighs Safety Worries

 
• By Brenda Sandburg
Liver
Mallinckrodt's terlipressin for hepatorenal syndrome gets nod from FDA panel • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers